pSivida Corp


Company Update (NASDAQ:PSDV): pSivida Corp. CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr.

Stock Update (NASDAQ:PSDV): pSivida Corp. Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur™ for Uveitis

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced positive top line results …

Company Update (NASDAQ:PSDV): pSivida Corp. Announces Top-Line Results from Investigator-Sponsored Phase II Study of Medidur™ for Uveitis to Be Reported Next Week

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that top line results from …

Stock Update (NASDAQ:PSDV): pSivida Corp. CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced Dr.

Stock Update (NASDAQ:PSDV): pSivida Corp. Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced positive safety data from …

Company Update (NASDAQ:PSDV): pSivida Corp. Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company

pSivida Corp. (NASDAQ:PSDV), a leader in developing sustained release, drug delivery products for treating eye diseases, announced that it has signed two funded …

Company Update (NASDAQ:PSDV): pSivida Corp. Reports Third Quarter FY 2015 Results

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release, drug delivery products for treating eye diseases, announced financial results for its …

Stock Update (NASDAQ:PSDV): pSivida Corp. Reports ILUVIEN® for DME Approved in Poland

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that the Office for …

MLV Reiterates Buy on pSivida Corp. as Medidur Phase 3 Enrollment Completed

MLV’s healthcare analyst Arlinda Lee weighed in with her views on pSivida Corp. (NASDAQ:PSDV) following the news that the company has completed enrollment in the Phase 3 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts